SLC13A5 and angioosteohypertrophic syndrome: Whole-exome sequencing has revealed molecular lesions that are associated with KTS, identifying mutations in two independent loci, ROGDI [2–6] and SLC13A5 (solute carrier family 13 member 5) [7–10], as the genetic causes of KTS.